R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.
about
Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes.New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.Clinical Characteristics and Risk of Relapse for Patients with Stage I-II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy.Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
P2860
R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@en
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@nl
type
label
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@en
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@nl
prefLabel
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@en
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1476
R-CHOP regimen can significant ...... diffuse large B-cell lymphoma.
@en
P2093
Chang-Gong Zhang
Feng-Yi Feng
Jian-Liang Yang
Shan Zheng
Sheng Yang
Sheng-Yu Zhou
P2860
P304
P356
10.5732/CJC.011.10420
P577
2012-05-23T00:00:00Z